Showing results (41-50 of 82) with videos related to
Sort By:
Pageof 9
Genes, Chromosomes & Cancer|July 25, 2019
Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemiaJordi Ribera, Lurdes Zamora, Mireia Morgades, et al.Blood Neoplasia|January 15, 2026
Dual FLT3/PIM inhibitor dapolsertib in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trialGiovanni Martinelli, Scott R Solomon, Sudipto Mukherjee, et al.Cancer|October 30, 2024
A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYXEduardo Rodríguez-Arbolí, Rebeca Rodríguez-Veiga, Elena Soria-Saldise, et al.Leukemia Research|March 26, 2018
Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemiaJosep-Maria Ribera, Olga García, Cristina Gil, et al.Leukemia & Lymphoma|July 29, 2021
A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemiaKendra Sweet, Bhavana Bhatnagar, Hartmut Döhner, et al.Blood Advances|February 9, 2021
Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trialCatia Simoes, Bruno Paiva, David Martínez-Cuadrón, et al.Cancer|April 24, 2019
Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA GroupJosep-Maria Ribera, Olga García, María-José Moreno, et al.Journal for Immunotherapy of Cancer|June 13, 2020
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivoMatteo Libero Baroni, Diego Sanchez Martinez, Francisco Gutierrez Aguera, et al.Cancer Medicine|February 6, 2020
A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trialJosep-Maria Ribera, Mireia Morgades, Pau Montesinos, et al.Leukemia Research|November 24, 2018
A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patientsDavid Martínez-Cuadrón, Cristina Gil, Josefina Serrano, et al.Pageof 9